Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury

Liliana Moreno-Vinasco, Hector Quijada, Saad Sammani, Jessica Siegler, Eleftheria Letsiou, Ryan Deaton, Laleh Saadat, Rafe S. Zaidi, Joe Messana, Peter H. Gann, Roberto F. Machado, Wenli Ma, Sara M. Camp, Ting Wang, Joe G N Garcia

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds